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The amorphous aggregation of proteins is associated with many phenomena, ranging from the formation of
protein wine haze to the development of cataract in the eye lens and the precipitation of recombinant proteins
during their expression and purification. While much literature exists describing models for linear protein
aggregation, such as amyloid fibril formation, there are few reports of models which address amorphous
aggregation. Here, we propose a model to describe the amorphous aggregation of proteins which is also more
widely applicable to other situations where a similar process occurs, such as in the formation of colloids and
nanoclusters. As first applications of the model, we have tested it against experimental turbidimetry data of
three proteins relevant to the wine industry and biochemistry, namely, thaumatin, a thaumatinlike protein, and
␣-lactalbumin. The model is very robust and describes amorphous experimental data to a high degree of
accuracy. Details about the aggregation process, such as shape parameters of the aggregates and rate constants,
can also be extracted.
DOI: 10.1103/PhysRevE.80.051907

PACS number共s兲: 87.15.km, 87.10.Ed, 87.15.nr

I. INTRODUCTION

Amorphous or disordered aggregation is a process that
occurs often in nature. For example, it is associated with
several age-related diseases such as cataract 关1兴 and can result in the formation of protein haze in white wines 关2兴. It is
also the bane of protein expression and purification for many
biochemists, leading to protein precipitation and subsequent
loss of protein, data, and time. Despite amorphous protein
aggregation being such a significant problem, it has received
little research attention and is often overshadowed by studies
of protein aggregation leading to highly structured linear
amyloid fibrils associated with neurodegenerative disorders,
such as Alzheimer’s and Parkinson’s diseases 关3兴.
Crystallin proteins in the eye lens are thought to be destabilized due to a lifetime of oxidative and radiative stress and
unfold into aggregation-prone species that are precursors to
cataract formation 关4兴. Cataract affects many aged people
and is a particular problem in developing countries where, as
a result, an estimated 24 million people are blind 关5兴. Currently, the principal treatments for cataract are removal of the
opacified lens and replacement with an artificial lens 关6兴.
Protein wine haze presents a significant problem to the
wine industry. Currently, bentonite clay is used to adsorb the
troublesome proteins from white wine which is then filtered
back off the clay 关2兴. While this is effective in removing the
proteins, it adversely affects the quality and quantity of the
treated wine and also presents waste disposal issues 关7兴. It is
estimated that the cost of bentonite fining to the wine industry worldwide is in the order of $300–500 million per annum
关7兴. Studies that describe the mechanism of protein wine

haze formation are highly desirable as they will lead to improved technologies, maintaining wine quality and decreasing the costs of production 关2兴.
In order to find solutions to these problems, there is a
need to understand and model the processes and kinetics of
the amorphous aggregation phenomena. There are many
mathematical models in the literature for linear aggregation
mechanisms, as reviewed by Morris et al. 关8兴. A unique approach was undertaken by Flyvbjerg et al. 关9,10兴, who studied the self-assembly of microtubules, a linear aggregation
mechanism, and derived a mathematical model to describe
the phenomenon. However, there are few, if any, mathematical models of amorphous aggregation. In this paper, we propose a model for amorphous aggregation processes and demand that certain constraints, which are found by performing
a data analysis similar to that by Flyvbjerg et al. 关9兴, are
imposed. The data shown here are turbidity measurements
for the aggregation of heat-stressed thaumatin, a protein
structurally very similar to thaumatinlike 共TL兲 proteins,
which play a major role in protein wine haze formation 关11兴.
We fit these data using our amorphous aggregation model.
The analysis is also performed on ␣-lactalbumin 共␣-LA兲, a
well-characterized protein that amorphously aggregates upon
reduction of its disulfide bonds 关12兴, and is often used as a
test protein to monitor the activity of molecular chaperone
proteins 关12,13兴. In addition, we monitor the aggregation of,
and apply our model to, a Vitis vinifera TL grape protein.
These three diverse proteins give very similar results, indicating the broad application of the model and its applicability
to other systems which behave in a similar manner, such as
the formation of colloids and nanoclusters 关14,15兴 and vapor
condensation 关16兴.
II. EMPIRICAL DATA ANALYSIS

*Present address: School of Biological Sciences, University of
Wollongong, Wollongong, NSW 2522, Australia.
†
Corresponding author; lorenz.smekal@physik.tu-darmstadt.de
1539-3755/2009/80共5兲/051907共13兲

Figure 1共a兲 shows a set of experimental turbidity 共A兲 data
for a range of initial concentrations of thaumatin 共between
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FIG. 1. 共a兲 Typical experimental data for thaumatin at various initial concentrations, incubated at 60 ° C in a model wine solution 共see
Appendix A for details兲. The dashed line overlaid shows the fits to the data by the model derived in this paper with a spherical exponent,
␥ = 2 / 3 ⬇ 0.67. 共b兲 The experimental data from 共a兲, with the time and turbidity axes scaled by the half time, t0, and asymptotic turbidity, A⬁,
respectively, for each series. The data sets “collapse” to a single curve, thus obeying a scaling law. The dashed curve represents the same
unique fit by the model to this scaled data 共with ␥ = 0.67兲 as the family of curves in 共a兲.

Consequently, without the use of any theory, we have empirically obtained two independent constraints on our model
from the experimental observations—the scaling and power
laws.
III. MODEL
A. Linear versus amorphous aggregation

In simplistic terms, the aggregation of monomeric entities
共e.g., proteins兲 to form linear chains such as amyloid fibrils
and the self-assembly of microtubules, as modeled by 关9兴,
are linear mechanisms; the aggregating “monomers” can
Replicate A
Replicate B
Replicate C
Replicate A Fit
Replicate B Fit
Replicate C Fit

16

t0 [min]

2.0 and 4.0 mg/ml兲 upon heating at 60 ° C. Overlaid are fits
by the model to the experimental data. Data and fits for the
TL protein and ␣-LA are shown in Figs. 7 and 8 of Appendix
A, respectively.
The data points follow similar sigmoidal curves, with initial lag times, followed by a steep rise and subsequent plateau. The curves differ only by the magnitude of the increase
in turbidity due to different initial protein concentrations; the
lag times are very similar. Therefore, the issue of whether
they differ only through the overall time and turbidity axes is
addressed following the reasoning of Flyvbjerg et al. 关9兴. If
that is the case, then the curves are said to “scale” over one
another, following a scaling law.
We do this by finding the asymptotic turbidity, A⬁, and the
time taken to reach half this value, the half time, t0, for each
data set. Upon scaling the turbidity and time axes with their
respective characteristic parameters, the data collapse to a
single curve 关Fig. 1共b兲 and Figs. 7 and 8 in Appendix A兴. The
interpretation of this is that, independent of the initial monomer concentration, a single mechanism of protein aggregation is present over the concentration range considered. This
allows use of a single curve for the modeling which may be
unscaled to reproduce the original data.
Furthermore, we seek to obtain a relationship between the
characteristic parameters A⬁ and t0. Following the analysis in
Ref. 关9兴, a double-logarithmic plot of t0 versus A⬁ yields a
straight line 共Fig. 2 and Figs. 9 and 10 in Appendix B兲,
which indicates a power law relationship of the form

14

12
0.2

t0 = A⬁−m ,

共1兲

where 共−m兲 is the slope of the double-logarithmic plot and 
is some constant of proportionality.
For thaumatin, the mean result of the three replicates is
m = 0.077⫾ 0.002, where the quoted error is the SE of the
mean. For the grape TL protein and ␣-LA, we obtain m
= 0.039⫾ 0.011 and 2.04⫾ 0.39, respectively 共see Figs. 9 and
10 in Appendix B兲.

0.4

0.6

0.8

1

A inf

FIG. 2. Double logarithmic plots of t0 against A⬁ for thaumatin,
showing all three replicates. The linear fits of log10共t0 / 兲 versus
log10共A⬁兲 for replicates A–C give slopes 共−m兲 of −0.074, −0.080,
and −0.075, R2 values of 0.98, 0.99, and 0.82, and  values of
13.65, 12.90, and 13.87 min, respectively, corresponding on these
plots to the t0 values with A⬁ = 1.0. This gives mean values of m
= 0.077⫾ 0.002 and  = 13.48⫾ 0.29 min, where errors are quoted
as standard errors 共SEs兲 of the mean.
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FIG. 3. Left: linear aggregation mechanisms are ordered onedimensional processes and monomers can only add onto the ends of
the aggregate chain. Right: amorphous aggregation is a disordered
three-dimensional process, where monomers can add on to aggregates from any direction.

only add on to either end of the aggregate in a onedimensional ordered manner. As the aggregate increases in
length, the rate of aggregation should therefore not increase
because there is no greater surface area available to the
monomers.
Conversely, amorphous aggregation can be thought of as a
disordered three-dimensional process, where monomers can
add from any direction. Consequently, we must account for
the fact that as the aggregates increase in size, the surface
area available to the monomers increases and hence there
should be a corresponding increase in the rate of aggregation. This will be the third constraint on the model, in addition to the scaling and power laws. Figure 3 compares the
linear and amorphous aggregation mechanisms schematically.
B. General framework

A similar formalism to that introduced in Refs. 关9,10兴 is
followed here. We let M共t兲 denote the total mass of monomers contained in the aggregates and c共t兲 be the monomer
concentration 共both in units of arbitrary concentration, such
as mass density兲. Clearly, conservation of mass gives us the
relation 关9,10兴
M共t兲 + c共t兲 = c共0兲,
共2兲
where c共0兲 ⬅ c0 is the initial protein monomer concentration
共at time t = 0兲. In addition, we see from Eq. 共2兲 that M ⬁, the
asymptotic mass as time approaches infinity, is equal to the
initial monomer concentration, c0, because c共t兲 goes to zero
关9,10兴. Furthermore, it is assumed that turbidity, A共t兲, is proportional to the aggregate volume and hence mass in aggregates, M共t兲.1 Thus, we see that A⬁ ⬀ M ⬁ = c0.
Note that the asymptotic turbidities, A⬁, thus scale linearly with the initial monomer concentration, c0. Inspection
of Fig. 1 indicates that experimentally, the linear correlation
between A⬁ and c0 is only approximate and we attribute this
primarily to experimental errors in preparing the monomer

concentrations. In any case, the exact values for concentration are not important and are not required in the analysis at
any point. It is only necessary to obtain data sets for different
concentrations for a given protein.
The data shown are all relative to the asymptotic turbidity
at the reference concentration, cref
0 = 4.0 mg/ ml.
The scaling law observed earlier gives motivation to introduce dimensionless “scaling variables.” Therefore, we define t⬘, A⬘, M ⬘, and c⬘ such that
t⬘ =

A⬘ =

A
,
A⬁

M⬘ =

M M
= ,
M ⬁ c0

c⬘ =

c
,
c0

共3兲

−m
with cref
where t0 = A⬁−m = 共c0 / cref
0 兲
0 = 4.0 mg/ ml and the
exponent m ⬎ 0 is the parameter determined earlier for each
of the proteins. This accounts for the power law constraint of
Eq. 共1兲.

C. Amorphous aggregation model

The mass in the aggregates, M共t兲, will increase with time
as monomers continue to add onto the cluster. The rate of
this increase will depend on the concentration, c, of available
monomers. One therefore expects that on one hand, this rate
will obey a power law of the form
dM
⬀ cr
dt

共4兲

for some as yet undetermined exponent, r ⱖ 0. We keep this
power general, allowing it to deviate from the classical value
of 1 for simple first-order kinetics. First of all, our system is
heterogeneous—the “reacting” monomer entities need to first
be activated by being partially unfolded. The denaturation
process, e.g., achieved by heating, results in a statistical distribution of monomer states, some of which are completely
unfolded, others which remain in their native form, and
many others in between, i.e., which are partially unfolded.
Thus, only a certain proportion s is able to aggregate at any
given time. Moreover, in the presence of density dependent
mechanisms, such as collisions between monomers which
may lead to activation or refolding, it is to be expected that
this proportion also depends on their density, as modeled, for
example, by another power law, s ⬀ c␦, leading to r = 1 + ␦.
Hence we allow for deviation from r = 1 in Eq. 共4兲.
On the other hand, we must also take into account the
requirement that the rate of aggregation increases as the aggregates grow in size. Assuming for simplicity that their average size grows in proportion to some other power, ␥, of
their mass, M, we require a factor of the form
dM
⬀ M␥ ,
dt

1

This relationship holds when treating the turbidity measurements
as being due to Rayleigh scattering, where the size of the aggregates
is much less than the wavelength used to analyze them 关17兴. Transmission electron microscope images 共not shown兲 verified this,
where only the largest protein aggregates just exceed the wavelength of the turbidity measurements, 340 nm. Nevertheless, the
approximation is valid for the majority of the aggregation time series and is therefore assumed to hold for the entire process.

t
,
t0

共5兲

where the exponent ␥ ⱖ 0 is also a priori unknown. Combining Eqs. 共4兲 and 共5兲, we obtain a rate equation of the form
dM
= fcrM ␥ ,
dt
where the constant f is to be determined experimentally.
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FIG. 4. Left column, A1–C1: thaumatin experimental data with the time and turbidity axes scaled with the half time, t0, and asymptotic
turbidity, A⬁, respectively. The three figures represent three repetitions of the experiment 共replicates A–C兲. The solid curves are the fits by
the model to the scaled data with ␥fit values and the dashed curves are fits by the isotropic 共iso兲 model with ␥ = 0.67. Right column, A2–C2:
thaumatin experimental data from the left column unscaled to reproduce the original time series, overlaid with the fits by the model using ␥fit
for each.

In order to account for the observed scaling, we first introduce the dimensionless variables of Eq. 共3兲. In terms of
these variables, Eq. 共6兲 reads
dM ⬘
␥
r
␥
= cr+
共7兲
0 f ⬘c ⬘ M ⬘ .
dt⬘
m
Herein, f ⬘ = 共cref
0 兲 f is a scaled dimensionless rate constant
to determine the overall rate of the process.
cm+1
0

The observed scaling requires the rate equation in terms
of the scaling variables 关Eq. 共7兲兴 to be independent of the
initial concentration, c0, as in Refs. 关9,10兴. Therefore, an additional constraint is r = m + 1 − ␥. With the power law in Eq.
共1兲 and scaling, the amorphous aggregation model then predicts an exponent in Eq. 共4兲 different from r = 1 whenever
m ⫽ ␥.
Since Eq. 共2兲 tells us that c⬘ = 1 − M ⬘, the final equation for
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0.005

the amorphous aggregation model, including an appropriate
initial condition, then reads
M ⬘共0兲 = 0.

0.004

共8兲

While the exponent m is obtained from the empirical data
analysis discussed above, the exponent ␥, introduced in Eq.
共5兲, and the rate constant f ⬘ may be used to model different
systems.

Replicate A
Replicate B
Replicate C

0.003

σ2

dM ⬘
= f ⬘共1 − M ⬘兲m+1−␥M ⬘␥,
dt⬘

0.002

0.001

D. General solution

To allow for a potential lag time before the onset of aggregation, we introduce a characteristic parameter tlag
⬘ associated with the sigmoidal curves by replacing t⬘ → t⬘ − tlag
⬘ .
The general solution to Eq. 共8兲 is then found, by integration,
to be implicitly given by the equation
t⬘ =

M ⬘1−␥ 2F1共1 − ␥,1 + m − ␥ ;2 − ␥ ;M ⬘兲
⬘ ,
+ tlag
f ⬘共1 − ␥兲

共9兲

where 2F1 is a hypergeometric function defined by the expansion
⬁

2F1共a,b;c;z兲 = 兺

k=0

共a兲k共b兲k zk
,
共c兲k k!

共10兲

共a+k兲
are the
in which 共a兲k = a共a + 1兲共a + 2兲 . . . 共a + k − 1兲 = ⌫⌫共a兲
Pochhammer symbols and ⌫ is the gamma function 关18兴. For
z = M ⬘ in our case it is straightforward to verify that the series
converges because 0 ⱕ M ⬘ ⱕ 1.
Depending on the model assumptions, i.e., whether a lag
phase is to be included and/or whether the exponent ␥ is
fixed by a model assumption on the geometry of the amorphous aggregation process or used as a free parameter, we
have various options to fit the implicit solution of Eq. 共9兲 for
M ⬘共t⬘兲 to the scaled experimental data. We can either use the
effective rate constant f ⬘ as the only parameter 共with all others fixed兲 or include the aggregation geometry exponent ␥
and/or an additional lag time via tlag
⬘ to perform the fits, thus
including up to at most three free parameters.

E. Aggregation geometry

As discussed above, the exponent ␥ in the aggregation
rate equation is introduced to account for an increase in the
area available to the monomers to add on to the aggregate.
This area can be the total surface area of the aggregates in
some cases but it might be only some part of that in others.
The exponent ␥ describes how the effective area relevant to
the aggregation process 共i.e., presented to the monomers兲
increases with the volume and hence the mass of the aggregates.
In linear aggregation such as amyloid fibril formation, for
example, this effective area is independent of the volume
which corresponds to ␥ = 0 for one-dimensional aggregation.
Another interesting special case is that of an isotropic
aggregation process in three dimensions as also sketched in
Fig. 3. In this case, the effective area, Aeff, and hence rate of
aggregation increase with the square of the aggregate’s ra-

0.000
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0.2

0.4

γ

0.6

0.8

1.0

FIG. 5. Plot showing estimated variance between the fitted
curve and thaumatin experimental data for values of ␥ between 0
and 1. Replicates A–C yield ␥fit values 共i.e., minima of plots兲 of
0.45, 0.48, and 0.49, respectively, and a mean value of ␥fit
= 0.47⫾ 0.02, where the quoted error is the standard deviation. The
large jump in error near ␥ = 0.10 corresponds to ␥ ⬇ m, which leads
to a special case of the hypergeometric function solution.

dius R, while the volume V increases as R3. Therefore, at
constant density,
Aeff ⬀ V2/3 ⬀ M 2/3 .

共11兲

We call ␥ = 2 / 3 the exponent for spherical or isotropic aggregation.
Larger values, ␥ ⬎ 2 / 3, are possible when the area increases faster than that relative to the volume. This could be
due to a roughening of the surface, for example.
When a deformation develops, on the other hand, there
are preferential directions of aggregation singling out a certain fraction of the total surface, with the result that the relevant effective area, Aeff, will grow slower than the aggregate’s total surface. Simple examples are prolate
deformations which in the extreme case lead to linear aggregation again or oblate deformations. The latter might be
modeled by a flat cylinder of increasing radius R but constant
height. Then, only the outer wall of the cylinder attracts further monomers and the effective area increases only linearly
with the radius, Aeff ⬀ R, while the volume increases as R2.
This gives
Aeff ⬀ V1/2 ⬀ M 1/2 ,

共12兲

so that we call ␥ = 1 / 2 the exponent for cylindrical aggregation, which of course is a two-dimensional process.
IV. THAUMATIN RESULTS
A. Isotropic model

We first assume isotropic aggregation and fix ␥ = 2 / 3
⬇ 0.67 as the spherical exponent in our fits. The dashed lines
in Figs. 1共a兲 and 1共b兲 show the nonlinear regression fit to one
of the replicates for thaumatin, fixing ␥ = 2 / 3 and using f ⬘

051907-5
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TABLE I. Summary of experimentally and computationally derived parameters for the three proteins
analyzed.

m


共min兲

␥fit

0.077b ⫾0.002 c
0.039⫾ 0.011
2.04⫾ 0.39

13.5⫾ 0.3
12.1⫾ 0.1
48.6⫾ 13.2

0.47⫾ 0.02 d
0.37⫾ 0.09
0.56⫾ 0.18

Protein
Thaumatin
TL protein
␣-lactalbumin

r

a

0.61⫾ 0.02
0.67⫾ 0.08
2.48⫾ 0.21

t⬘lag

f̄ = f ⬘ / 
共min−1兲

0.55⫾ 0.03
0.63⫾ 0.03
0.11⫾ 0.06

0.25⫾ 0.01
0.27⫾ 0.01
0.09⫾ 0.03

r = 1 + m − ␥fit.
m, , ␥fit, and t⬘lag are each quoted as mean values across the repetitions.
c
All quoted errors are SEs of the mean across the repetitions of the experiments unless stated otherwise.
d
The errors in ␥fit are quoted as standard deviations 共SDs兲 to give a more generous error estimate to account
for the finite step size in the ␥ increment loops.
a

b

and tlag
⬘ as fitting parameters.2 This is the same fit as the
dashed line for replicate A1 in Fig. 4. Almost identical results are obtained for replicates B1 and C1 共dashed lines兲,
also shown in Fig. 4.
By inspection of the fits, the spherical exponent, ␥ = 2 / 3,
for isotropic 共iso兲 aggregation is very well suited to describe
the data for the earlier times, t ⬍ t0. At later times, t ⬎ t0, the
quality of the fits deteriorates, however. The assumption of
isotropic aggregation appears to break down in the final
phase of the process typically after the half time, t0.
B. Global fits

Since these observed deviations from the isotropic aggregation model could either be due to anisotropies in the aggregation or roughening of the surface, as explained above,
we adopt an alternative model in which the exponent ␥ is
varied to optimize the fits over a range of times around t0, so
chosen as to include the essential part of the aggregation
process 共excluding very early and very late times兲. To this
end, we scan the range of exponents 0 ⱕ ␥ ⬍ 1 in increments
of 0.01.3 This is done using a simple MATHEMATICA routine
to obtain for each value of ␥ a nonlinear regression fit using
f ⬘ and tlag
⬘ as the two free parameters. The estimate of the
variance is plotted for each value against ␥ in Fig. 5.4
The data range for the fits around t0 is chosen as 2 / 3
ⱕ t⬘ ⱕ 4 / 3.5 This window includes the majority of the crucial
2

The MATHEMATICA 共Wolfram Research, Champaign, IL兲 function
NonLinearRegress is used for all of the fitting procedures. In this
procedure, the estimates of the model 共fitting兲 parameters are chosen to minimize the 2 merit function, a function which measures
the difference between data and the fitting model for a particular
choice of the parameters given by the sum of squared residuals 关19兴.
3
Note that ␥ = 1 is a limiting case in that it leads to an exponential
growth at early times, while simple power laws M ⬘共t⬘兲 ⬃ t⬘1/共1−␥兲
are obtained at small t⬘ for 0 ⱕ ␥ ⬍ 1.
4
The MATHEMATICA statistical output EstimatedVariance is equivalent to the squared sum of fit residuals 共difference between data and
fit estimate at any point兲 divided by the number of degrees of freedom 关19兴.
5
The fitting window midpoint for ␥ = 2 / 3 was chosen to be the
inflection point which is reached slightly before the half time, t0.
The difference is insignificant, however.

central data and is mainly chosen to exclude the extremities.
The fits are otherwise stable under variations of this range
within reasonable limits.
For each of the three replicates we separately obtain a
value of ␥, termed ␥fit, minimizing the estimated variance,
2, as shown in Fig. 5. These values for the best fit over the
transition range lead to a global average over the three sets of
␥fit = 0.47⫾ 0.02 for thaumatin. Figures 11 and 12 in Appendix B, respectively, show similar plots for the TL protein and
␣-LA, resulting in ␥fit = 0.37⫾ 0.09 and ␥fit = 0.56⫾ 0.18, respectively.
Replicates A1, B1, and C1 in Fig. 4 show the fits 共solid
lines兲 resulting for each of the three sets of scaled thaumatin
experimental data 共symbols兲 obtained with their respective
optimized geometry exponents, ␥fit. An excellent agreement
between fit and data is observed, in particular at later times,
t ⬎ t0, where the isotropic model 共iso—dashed lines兲 starts to
fail.
V. DISCUSSION

Our interpretation of these results is that they provide
compelling evidence that the aggregation process for thaumatin is very well described by an isotropic threedimensional process 共corresponding to the spherical exponent, ␥ = 2 / 3兲 in the early phases leading up to the half time,
t0. After that, better fits are obtained for a value of ␥fit near
1/2 which implies that the aggregates start to develop more
of an oblate deformation eventually leading to an aggregation corresponding to the cylindrical exponent, ␥ = 1 / 2. The
two-dimensional model matches the data particularly well
during the late stages of the aggregation process and, in this
phase, it provides a very good description even considerably
beyond the range used for the fits.
Replicates A2, B2, and C2 in Fig. 4 show the original
thaumatin experimental data with the same fits using the ␥fit
values, but after the original scaling from the left column,
corresponding to Eq. 共3兲, is undone.
Table I gives a summary of the values obtained for the
various parameters of the three proteins. In order to compare
different systems such as different proteins, it is furthermore
useful to define a proper rate constant, f̄ ⬅ f ⬘ / , upon division by the characteristic time  from the power law of Eq.
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FIG. 6. 共a兲 Double logarithmic plot of thaumatin experimental aggregation 共turbidity兲 data from Fig. 1共a兲, showing early times. The data
follow a straight line behavior, and this property can be readily captured by the model. 共b兲 Thaumatin experimental aggregation 共turbidity兲
data from Fig. 1共a兲 for late times, presented as monomer concentration 共c ⬀ A⬁ − A兲. The plots exhibit asymptotic decay, and the inset shows
the A⬁ − A axis logarithmically, giving approximate straight line behavior. These late-time properties can be accounted for when setting r
= 1 which implies ␥ = m. The dashed line shows the original fit for c0 = 4.0 mg/ ml with ␥ = m = 0.08 as obtained from the power law in Eq.
共1兲. The solid line shows the result of an independent fit of this parameter to the late-time data resulting in m = ␥ = 0.45 which is precisely the
same value as obtained from the global fit for the geometry exponent ␥ to these data 关replicate A in Fig. 4 共see panel A2兲兴.

共1兲. This definition is independent of the reference concentration, cref
0 , used in the turbidity measurements, and the results for f̄ are also quoted in Table I. Details of corresponding analyses for the TL protein and ␣-LA are included in
Appendixes A and B.
We found that the values of r for thaumatin 共and the TL
protein兲 were less than 1, the value expected from first-order
kinetics. We rationalize this on the basis that heating is used
to activate the monomers for aggregation. As a result, a statistical distribution of monomers is present, some of which
are still in their native 共folded兲 form, others which are partially unfolded, and others which are completely unfolded.
Therefore, a certain proportion of the total monomers present
in the system is unavailable for aggregation 共e.g., those in the
native form兲. In physical terms, when this proportion is
smaller at larger densities, due to an increased number of
collisions for example, this can give rise to an r value decreased from 1. Conversely, the r value for ␣-LA was found
to be greater than 1. In this case, however, a reducing agent
was used to induce aggregation by breaking the four disulfide bonds of ␣-LA to cause the protein to partially unfold.
This chemical method results in practically all of the monomers being partially unfolded 关12兴 and therefore activated for
aggregation, and it can therefore not explain the observed r
value larger than 1. Rather, the resulting value of r around
2.5 may indicate that a few nucleation steps, where more
than one monomer is involved in forming the nuclei, might
need to be included in the pathway to aggregation for ␣-LA.
This is beyond the scope of the present model and will be
left as a future extension.
Further verification of the validity of the model requires a
thorough analysis of the early and late-time data. Figures
6共a兲 and 6共b兲 show the thaumatin experimental aggregation
data from Fig. 1共a兲 for early and late times, respectively,
emphasized on respective double-logarithmic and semilogarithmic axes 共the same trends are seen for the TL protein and
␣-LA data, not shown here兲. For the early-time case, the

monomer concentration changes very little 共c ⬃ c0兲, so the
entire system is described by Eq. 共5兲 only. Integrating this
equation gives
M ⬀ t1/共1−␥兲

共13兲

for early times. Therefore, our model predicts that doublelogarithmic plotting of early-time aggregation data should
result in straight lines 共of slope 1−1␥ 兲. This behavior is observed very clearly as shown for thaumatin in Fig. 6共a兲
where we included the isotropic aggregation model fits with
␥ = 2 / 3 for the limiting values of the initial monomer concentrations from Fig. 1 to indicate the band of lines expected
for initial concentrations between 2.0 and 4.0 mg/ml. After
about 2 min the data align with this band and we conclude
that the three-dimensional isoptropic model with M ⬀ t3 captures the early-time behavior of the aggregation process very
well.
For the case of late times, one might intuitively expect a
simple exponential decay of the monomer concentration.
However, this requires r = 1 + m − ␥ = 1. Otherwise the aggregation process would be fully completed in maybe large but
strictly speaking finite time as can be seen from Eq. 共9兲
which results in a finite t⬘ = tmax
⬘ for M ⬘ = 1 when 1 + m − ␥
= r differs from 1. As this would appear to be rather unphysical we must assume that r = 1 at least asymptotically at late
times. Then, from Eq. 共9兲,
m
M ⬁ − M ⬀ exp关− 共c0/cref
0 兲 f̄t兴,

共14兲

where the constant of proportionality depends on ␥ = m.
The late-time data for M ⬁ − M of thaumatin are compared
to such model solutions with r = 1 and exponential decay in
Fig. 6共b兲. The dashed line is obtained when using the value
of the exponent m from the power law 关Eq. 共1兲兴, i.e., with
␥ = m = 0.08. The solid line is the result of an independent fit
of this parameter to the late-time data which incidentally
leads to a value ␥ = m = 0.45 coinciding with the result of the
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global fit for the geometry exponent ␥fit to these data, replicate A 关see Fig. 4 共A2兲兴, as described in Sec. IV B. Identical
values are obtained for replicates B and C with very small
errors. They are all consistent with the thaumatin average of
the global fit parameter ␥fit = 0.47⫾ 0.02 for approximately
cylindrical aggregation, as listed in Table I.
The late-time data are then also well described, and we
observe that the extracted value of the geometry exponent is
insensitive to the necessary modification of r. We reiterate,
however, that r = 1 is required for the expected exponential
decay of the monomer concentration at late times. The fact
that this is in conflict with the empirical value of r used so
far shows the limitation of the model. An obvious improvement would, of course, be to assume that the required deviations from r = 1 in Eqs. 共4兲 and 共6兲 tend to zero, i.e., that r
→ 1 at late times. In physical terms such a modification
would be very well justified. For thaumatin and the TL protein this is because one would expect the density dependence
of the activation process to die off as monomer collisions do
when their density approaches zero. Likewise, the compensation for potential nucleation steps in the case of ␣-LA, by
adjusting the value of r to around 2.5, should really only be
applied during the early phases with r → 1 after nucleation.
The overall effect of this modification is expected to be
small, however, because the model describes the data very
well over almost the entire aggregation process, including
the depletion of monomers and the subsequent plateau region, as seen, e.g., in Fig. 4. Furthermore, the predicted geometry exponent is seen to be left unaffected. We therefore
conclude that implementing r → 1 might be a rather cosmetic
improvement. In doing so, the model would probably lose its
mathematical simplicity which is one of its most appealing
features.
Another limitation of the model in its present form is that
there is no reference made to individual aggregates and their
numbers. As a result, the model does not allow for the case
where alternative growth pathways exist depending on the
concentration of certain sizes of aggregates. For example, for
large aggregate sizes, clumps of these big aggregates may
begin to form rather than the simple addition of individual
monomers to growing clusters. Therefore, further extensions
of the model would need to account for a variable size distribution in order to rationalize and incorporate multiple aggregation pathways.
VI. CONCLUSIONS AND OUTLOOK

In this paper, we have proposed a model for aggregation
involving a geometry exponent ␥ to model its various forms
including the well-studied one-dimensional linear processes
for ␥ = 0, two-dimensional or cylindrical processes for ␥
= 1 / 2, and isotropic three-dimensional processes with ␥
= 2 / 3. Moreover, this exponent can provide an indication of
the geometry of the process and changes in geometry of the
aggregates over time.
While simple in its form, the model is widely applicable
to a number of amorphous aggregation processes, not necessarily limited to protein aggregation. To use this model on
other systems, the experimentally obtained data simply need

to be proportional to the volume of the aggregates and obey
a scaling law; the method is, therefore, not limited to turbidimetry data.
Nevertheless, this model is very well suited to describe
the turbidimetry data for the thaumatin protein presented
herein as a first example. In particular, for thaumatin we
observe that the first half of the aggregation process is very
well described by an isotropic three-dimensional form corresponding to ␥ = 2 / 3, while the second half displays more of a
two-dimensional cylindrical behavior with ␥ ⬇ 1 / 2. Similar
results are obtained for a TL protein and ␣-LA 共whereby the
rather limited scaling properties of the ␣-LA system lead to
somewhat larger uncertainties—see Appendixes A and B兲.
A possible explanation for the geometry change at later
times for the thaumatin protein may be that the hydrophobic
interactions between aggregate and monomer are the primary
modes of attraction 关20兴 and, therefore, not all of the surface
of an aggregate is available for a monomer to add. This is
particularly the case for larger aggregates, where the hydrophobic regions will tend to point inward, exposing as little
hydrophobicity as possible to the aqueous solution and hence
reducing the number of sites available for monomers to add.
Oblate deformations may result along with growth with reduced dimensionality in preferred directions. Whether it does
or whether it leads to some other means to reduce the effective area relative to the volume is an open question which
deserves further study.
An alternative explanation for the decrease in ␥ for later
times could be that big aggregates might clump together to
form huge aggregates. This would decrease the effective surface area available for monomer addition, consistent with the
␥ change. Furthermore, such a competing process would be
more likely for later times when there are fewer monomers
present and only big aggregates remain. Extensions of the
model would need to account for such multiple growth pathways which depend on the size distribution of the aggregates
at any time.
An analysis of the early-time behavior of the model
shows that it is consistent with the experimental data and
physical observations. On the other hand, we need to assume
that r → 1 at late times to avoid the unphysical situation of a
finite aggregation time. This is a minor limitation of the
model which has little effect on the aggregation process as a
whole. The model nevertheless reproduces the correct overall
trends even at late times.
Future work will also include tests of the model in other
systems. In addition, the findings could be reconciled with
other data, such as time series of protein hydrodynamic radii
as studied in 关21兴. Finally, one could incorporate the capacity
to include a number of nucleation steps prior to aggregation
in the model along the lines of the linear aggregation model
developed in Ref. 关9兴. This could then be used to devise a
criterion for whether nucleation is important or not in any
given amorphous aggregation process.
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FIG. 7. Left column, A1–C1: TL protein experimental data with the time and turbidity axes scaled with the half time, t0, and asymptotic
turbidity, A⬁, respectively. The three figures represent three repetitions of the experiment 共replicates A–C兲. The solid curves are the fits by
2
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APPENDIX A: MATERIALS AND METHODS
1. Materials

Thaumatin 共mixture of I and II兲 from Thaumatococcus
daniellii was purchased from MP Biomedicals 共Solon, OH,
USA兲 and calcium depleted, type III, ␣-LA was purchased
from Sigma Chemical Co. 共St Louis, MO, USA兲, both being
used without further purification. A thaumatinlike 共TL兲 protein was isolated 共⬎98% purity兲 from Semillon grape juice
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FIG. 8. Left column, A1–E1: ␣-LA experimental data with the time and turbidity axes scaled with the half time, t0, and asymptotic
turbidity, A⬁, respectively. The five figures represent five repetitions of the experiment 共replicates A–E兲. The solid curves are the fits by the
2
model to the scaled data with ␥fit values and the dashed curves are fits by the 共isotropic—iso兲 model with ␥ = 3 . Right column, A2–E2: ␣-LA
experimental data from the left column unscaled to reproduce the original time series overlayed with the fits by the model using ␥fit.

共Adelaide Hills, South Australia, 2005兲 by cation exchange
and hydrophobic interaction chromatography 关22兴. Dithiothreitol 共DTT兲 was obtained from Sigma. All buffers and
solutions were filtered 共0.45 m兲 before use.

2. Determining protein concentrations

Concentrations of thaumatin 共⑀280 = 27 755 M−1 cm−1,
mass= 22 204 Da 关23兴兲 and ␣-LA 共⑀280 = 28 540 M−1 cm−1,
mass= 14 000 Da 关24兴兲 were determined spectrophotometri-
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cally at 280 nm with a Cary 5000 UV-visible spectrophotometer 共Varian, Melbourne, VIC, Australia兲.
For the TL protein, the concentration of the final purified
protein was determined by high-performance liquid chromatography 关25兴.

Stock solutions of thaumatin 共5.0 mg/ml兲 in a model wine
buffer solution 共pH 3.2, 12% v / v ethanol/water, 1.25 g/l potassium hydrogen tartrate, and 1 g/l Na2SO4兲 were prepared.
Appropriate dilutions were made with the model wine buffer
to give protein concentrations in 0.5 mg/ml increments from
2.0 to 4.0 mg/ml plus a control containing no protein 共baseline兲. For the TL protein, the same model wine buffer was
used except the pH was 3.5 and 100 mM potassium malate
was included. The concentration range was 3.0–5.0 mg/ml in
0.5 mg/ml increments. Apo ␣-LA 共10 mg/ml兲 in phosphate
buffer 共pH 7.2, 50 mM Na3PO4, 100 mM NaCl, and 2.5 mM
ethylenediamine tetra-acetic acid兲 was used from 2.0–4.0
mg/ml in 0.5 mg/ml increments.
Incubation was at 60 ° C with 2 s of shaking after each 30
s cycle for thaumatin and the TL protein. The ␣-LA aggregation experiments were performed at 37 ° C 共no shaking兲
and initiated by including DTT to a final concentration of 20
mM. The aggregation was monitored via turbidimetry at 340
nm using a Fluostar Optima microplate reader 共BMG Labtechnologies, Melbourne, VIC, Australia兲. The data in each
assay were averaged between duplicates and baseline subtracted, then normalized using the A⬁ value for 4.0 mg/ml
共cref
0 兲 for each repetition such that the A⬁ turbidity values for
4.0 mg/ml were always 1.0 共justifiable because turbidity is an
arbitrary scale兲. This procedure produced the aggregation
profiles in the right column of Fig. 4 and those of Figs. 7 and
8, whereby the thaumatin and TL protein experiments were
repeated three times and five times for ␣-LA due to the
greater variability in the data.

12.4
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3. Monitoring aggregation by turbidimetry
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FIG. 9. Double logarithmic plots of t0 against A⬁ for the TL
protein, showing all three replicates. The linear fits of log10共t0 / 兲
versus log10共A⬁兲 for replicates A–C, respectively, give slopes
共−m兲 of −0.033, −0.024, and −0.061, R2 values of 0.62, 0.34, and
0.56, and  values of 11.83, 12.12, and 12.29 min, corresponding on
these plots to the t0 values with A⬁ = 1.0. This gives mean values of
m = 0.039⫾ 0.011 and  = 12.08⫾ 0.13 min, where errors are quoted
as SEs of the mean.

the data are slightly more noisy than for thaumatin. Replicates A1, B1, and C1 of Fig. 7 show that a ␥ value of 0.67
共the isotropic model兲 gives better fits for the early-time TL
protein data, but the value which gives the best fit for mid to
later times is ␥ ⬇ 0.40 共i.e., ␥fit from Fig. 11兲. Therefore, the
same interpretation can be used as with thaumatin—there
appears to be a change in the aggregate geometry from isotropically aggregating entities for early times, t ⬍ t0, to cylindrically aggregating entities for mid to later times, t ⬎ t0.
Since the change in ␥ is more significant for the TL protein
500
400

APPENDIX B: TL PROTEIN AND ␣-LA RESULTS AND
DISCUSSION

300
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Inspection of Figs. 7 and 8 共left columns兲 shows that the
individual data for the aggregation of the TL protein and
␣-lactalbumin 共␣-LA兲, respectively, “scale” to an approximation. This allows us to use the scaling technique to analyze the data and fit the model to them in the same manner as
described for thaumatin. It should be noted, however, that the
scaling for ␣-LA is not as consistent as for thaumatin and the
TL protein.
Once again, the double-logarithmic plots of the characteristic parameters produce straight lines for both the TL protein
共Fig. 9, m = 0.039⫾ 0.011兲 and ␣-LA 共Fig. 10, m
= 2.04⫾ 0.39兲. The value of m for the TL protein is of the
same order as thaumatin, but ␣-LA is two orders of magnitude greater than the other two. This is likely to be due to its
dramatically different aggregation profile and that the conditions used to induce aggregation 共i.e., reduction versus heating兲 lead to a much longer period of aggregation.
The fits by this amorphous aggregation model to the TL
protein data produce strong correlations 共Fig. 7兲 even though
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FIG. 10. Double logarithmic plots of t0 against A⬁ for ␣-LA,
showing all five replicates. The linear fits of log10共t0 / 兲 versus
log10共A⬁兲 for replicates A–E, respectively, give slopes 共−m兲 of
−2.90, −1.64, −2.04, −2.81, and −0.80, R2 values of 0.98, 0.53,
0.98, 0.99, and 0.99, and  values of 27.7, 56.7, 36.8, 25.2, and 96.7
min, corresponding on these plots to the t0 values with A⬁ = 1.0.
This gives mean values of m = 2.04⫾ 0.39 and  = 48.6⫾ 13.2 min,
where errors are quoted as SEs of the mean.
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FIG. 11. Plot showing estimated variance between the fitted
curve and the scaled TL protein experimental data for values of ␥
between 0 and 1. Replicates A–C yield ␥fit values 共i.e., minima of
plots兲 of 0.36, 0.28, and 0.46, respectively, and a mean value of
␥fit = 0.37⫾ 0.09, where the quoted error is the standard deviation.

than thaumatin, it suggests that these effects are more exaggerated in the TL case, perhaps leading to greater oblateness.
The greater approximation to scaling for the ␣-LA data
makes it difficult to draw any firm conclusions about whether
the fits are improved by changing the geometry exponent, ␥.
Figure 8 共replicates A1–E1兲 shows the fits to the scaled data
by the model and it is difficult to distinguish whether the fit
is improved by ␥ = 0.67 共iso兲 or ␥fit 共from Fig. 12兲. While the
latter gives a lower overall error in the fit, we cannot conclude with greater confidence whether ␥ = 0.67 gives better
fits at early times. Therefore, we cannot interpret whether a
change in aggregate shape occurs for ␣-LA. Nevertheless,
the same overall trend is observed, that is ␥fit is near 0.5.
The less consistent scaling of ␣-LA could be due to the
longer time period of aggregation exaggerating the effect of
scaling with t0. It could also be due to the greater variation of
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